Advertisement

Supply Chain



The FDA cracked down on its policy for COVID-19 antibody tests after public health officials raised concerns over the quality of the tests, which were allowed on the market without FDA review, Politico reported. 

After recommending that hospitals and ambulatory surgery centers postpone surgeries in mid-March in light of the COVID-19 pandemic, the Centers for Medicare & Medicaid Services (CMS) announced guidelines on April 19 that detail how facilities can begin to resume procedures.1

Advertisement

Most Read

Advertisement
Advertisement